Control of HIV despite the discontinuation of antiretroviral therapy [2]

New England Journal of Medicine

Volumn 340, Issue 21, 1999, Pages 1683-1684

  Lisziewicz, J ^a   Rosenberg, E ^a   Lieberman, J ^a   Jessen, H ^a   Lopalco, L ^a   Siliciano, R ^a   Walker, B ^a   Lori, F ^a  

^a Research Institute for Genetic Human Therapy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; DIDANOSINE; GAG PROTEIN; HYDROXYUREA; INDINAVIR; T LYMPHOCYTE ANTIGEN; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

CASE REPORT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG WITHDRAWAL; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LETTER; LYMPHOCYTE COUNT; PRIORITY JOURNAL; SEROCONVERSION; VIREMIA; BLOOD; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; IMMUNOLOGY; ISOLATION AND PURIFICATION; VIROLOGY;

ANTI-HIV AGENTS; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; HIV; HIV INFECTIONS; HUMANS; RNA, VIRAL; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0033609174     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199905273402114     Document Type: Letter

References (5)